AML
Clinical trials for AML explained in plain language.
Never miss a new study
Get alerted when new AML trials appear
Sign up with your email to follow new studies for AML, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat blood cancer
Disease control CompletedThis study tested whether adding the drug lenalidomide to a standard three-drug chemotherapy regimen (MEC) could improve outcomes for adults with acute myeloid leukemia (AML) that has returned after treatment or didn't respond to initial therapy. The goal was to see if this combi…
Matched conditions: AML
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First human tests begin for potential blood cancer treatment
Knowledge-focused CompletedThis early-stage study tested a new drug called ZE46-0134 in healthy volunteers to check its safety and how the body processes it. Researchers gave different doses to 112 healthy adults to monitor for side effects and measure drug levels in the blood. The study was completed and …
Matched conditions: AML
Phase: PHASE1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC